Zobrazeno 1 - 10 of 260 pro vyhledávání: '"Peixoto da Silva S"'
1
Akademický článek
Chemosensitizing effect of pentoxifylline in sensitive and multidrug-resistant non-small cell lung cancer cells.
Autor: Matos BS; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal., Peixoto da Silva S; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto 4050-313, Portugal., Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, Porto 4050-313, Portugal., Xavier CPR; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, Rua Alfredo Allen 208, Porto 4200-135, Portugal.; UCIBIO - Applied Molecular Biosciences Unit, Toxicologic Pathology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), Gandra 4585-116, Portugal.; Associate Laboratory i4HB - Institute for Health and Bioeconomy, University Institute of Health Sciences - CESPU, Gandra 4585-116, Portugal.
Publikováno v: Cancer drug resistance (Alhambra, Calif.) [Cancer Drug Resist] 2024 May 20; Vol. 7, pp. 19. Date of Electronic Publication: 2024 May 20 (Print Publication: 2024).
Zobrazit plný text záznamu
2
Akademický článek
Decoding the role of inflammation-related microRNAs in cancer cachexia: a study using HPV16-transgenic mice and in silico approaches.
Autor: Santos JMO; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319, Porto, Portugal., Peixoto da Silva S; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319, Porto, Portugal., Bastos MMSM; LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering of the University of Porto, 4200-465, Porto, Portugal., Oliveira PA; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), Quinta de Prados, 5000-801, Vila Real, Portugal., Gil da Costa RM; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal.; LEPABE - Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering of the University of Porto, 4200-465, Porto, Portugal.; Centre for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), Inov4Agro, University of Trás-os-Montes and Alto Douro (UTAD), Quinta de Prados, 5000-801, Vila Real, Portugal.; Postgraduate Programme in Adult Health (PPGSAD), Department of Morphology, Federal University of Maranhão (UFMA), and UFMA University Hospital (HUUFMA), 65080-805, São Luís, Brazil., Medeiros R; Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP) / RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto) / Porto Comprehensive Cancer Center (Porto.CCC), 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Faculty of Medicine of the University of Porto (FMUP), 4200-319, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Research Department of the Portuguese League Against Cancer - Regional Nucleus of the North (Liga Portuguesa Contra o Cancro - Núcleo Regional do Norte), 4200-177, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.; Biomedical Research Center (CEBIMED), Faculty of Health Sciences of the Fernando Pessoa University, 4249-004, Porto, Portugal. ruimedei@ipoporto.min-saude.pt.
Publikováno v: Journal of physiology and biochemistry [J Physiol Biochem] 2022 May; Vol. 78 (2), pp. 439-455. Date of Electronic Publication: 2022 Mar 17.
Zobrazit plný text záznamu
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-A Proof of Concept.
Autor: Bergantim R; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital Center of São João, 4200-319 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal., Peixoto da Silva S; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal., Polónia B; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal., Barbosa MAG; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal., Albergaria A; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Research Innovation Unit, Translational Research & Industry Partnerships Office, i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal., Lima J; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Research Innovation Unit, Translational Research & Industry Partnerships Office, i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal., Caires HR; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal., Guimarães JE; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Clinical Hematology, Hospital Center of São João, 4200-319 Porto, Portugal.; Clinical Hematology, FMUP-Faculty of Medicine of the University of Porto, 4200-319 Porto, Portugal.; Instituto Universitário de Ciências da Saúde, Cooperativa de Ensino Superior Politécnico e Universitário IUCSESPU, 4585-116 Gandra-Paredes, Portugal., Vasconcelos MH; i3S-Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal.; Cancer Drug Resistance Group, IPATIMUP-Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135 Porto, Portugal.; Department of Biological Sciences, FFUP-Faculty of Pharmacy of the University of Porto, 4050-313 Porto, Portugal.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Nov 08; Vol. 23 (22). Date of Electronic Publication: 2022 Nov 08.
Zobrazit plný text záznamu
5
Akademický článek
miRNAs mediated drug resistance in hematological malignancies.
Autor: Peixoto da Silva S; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal., Caires HR; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal., Bergantim R; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Clinical Hematology, Hospital São João, 4200-319, Porto, Portugal; Clinical Hematology, FMUP - Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal., Guimarães JE; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Clinical Hematology, FMUP - Faculty of Medicine, University of Porto, 4200-319, Porto, Portugal; Instituto Universitário de Ciências da Saúde, Cooperativa de Ensino Superior Politécnico e Universitário, IUCSCESPU, 4585-116, Gandra, Paredes, Portugal., Vasconcelos MH; i3S - Instituto de Investigação e Inovação em Saúde, University of Porto, 4200-135 Porto, Portugal; Cancer Drug Resistance Group, IPATIMUP - Institute of Molecular Pathology and Immunology of the University of Porto, 4200-135, Porto, Portugal; Department of Biological Sciences, FFUP - Faculty of Pharmacy, University of Porto, 4050-313, Porto, Portugal. Electronic address: hvasconcelos@ipatimup.pt.
Publikováno v: Seminars in cancer biology [Semin Cancer Biol] 2022 Aug; Vol. 83, pp. 283-302. Date of Electronic Publication: 2021 Mar 20.
Zobrazit plný text záznamu
6
Akademický článek
Therapeutically Harnessing Tumor Cell-Derived Extracellular Vesicles for Multiple Myeloma: Recent Advances and Future Perspectives.
Autor: Xiao, Shumei1 (AUTHOR) xsmncdx2018@163.com, Chen, Lei2 (AUTHOR) lene918@163.com, Chen, Zhichao2 (AUTHOR) chenzhichao@hust.edu.cn, Li, Qiubai1,3 (AUTHOR) qiubaili@hust.edu.cn
Publikováno v: Pharmaceutics. Nov2024, Vol. 16 Issue 11, p1439. 23p.
Zobrazit plný text záznamu
7
Akademický článek
The Role of MicroRNA in the Pathophysiology and Diagnosis of Viral Myocarditis.
Autor: Młynarska, Ewelina1 (AUTHOR) ewelina.mlynarska@umed.lodz.pl, Badura, Krzysztof1 (AUTHOR), Kurciński, Szymon1 (AUTHOR), Sinkowska, Julia1 (AUTHOR), Jakubowska, Paulina1 (AUTHOR), Rysz, Jacek2 (AUTHOR), Franczyk, Beata1 (AUTHOR)
Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 20, p10933. 20p.
Zobrazit plný text záznamu
8
Akademický článek
Analysis of current status and influencing factors of cancer-related anorexia in patients undergoing chemotherapy for gynecological malignancies.
Autor: Mingna Lin1, Aimin Gong1, Bingqing Zhao1, Danyang Pan1 pandanyang712@163.com
Publikováno v: European Journal of Gynaecological Oncology. Oct2024, Vol. 45 Issue 5, p162-167. 6p.
Zobrazit plný text záznamu
9
Akademický článek
Systemic Metabolic and Volumetric Assessment via Whole-Body [ 18 F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell Carcinoma.
Autor: Yu, Josef1 (AUTHOR) josef.yu@meduniwien.ac.at, Spielvogel, Clemens1 (AUTHOR) clemens.spielvogel@meduniwien.ac.at, Haberl, David1,2 (AUTHOR) david.haberl@meduniwien.ac.at, Jiang, Zewen1 (AUTHOR) zewen.jiang@meduniwien.ac.at, Özer, Öykü1 (AUTHOR) oeykue.oezer@meduniwien.ac.at, Pusitz, Smilla1 (AUTHOR) smilla.pusitz@oegk.at, Geist, Barbara1 (AUTHOR) barbara.geist@meduniwien.ac.at, Beyerlein, Michael1 (AUTHOR) stefan.gruenert@meduniwien.ac.at, Tibu, Iustin1 (AUTHOR) marcus.hacker@meduniwien.ac.at, Yildiz, Erdem3 (AUTHOR) erdem.yildiz@meduniwien.ac.at, Kandathil, Sam Augustine3 (AUTHOR) sam.kandathil@meduniwien.ac.at, Buschhorn, Till3 (AUTHOR) till.buschhorn@meduniwien.ac.at, Schnöll, Julia3 (AUTHOR) julia.schnoell@meduniwien.ac.at, Kumpf, Katarina4 (AUTHOR) katarina.kumpf@meduniwien.ac.at, Chen, Ying-Ting5 (AUTHOR) ying-ting.chen@meduniwien.ac.at, Wu, Tingting6 (AUTHOR) wutingting@csu.edu.cn, Zhang, Zhaoqi7 (AUTHOR) zhang1979@hebmu.edu.cn, Grünert, Stefan1 (AUTHOR), Hacker, Marcus1 (AUTHOR), Vraka, Chrysoula1 (AUTHOR) chrysoula.vraka@meduniwien.ac.at
Publikováno v: Cancers. Oct2024, Vol. 16 Issue 19, p3352. 18p.
Zobrazit plný text záznamu
10
Akademický článek
Human Papillomavirus 16-Transgenic Mice as a Model to Study Cancer-Associated Cachexia.
Autor: Peixoto da Silva S; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Santos JMO; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal., Mestre VF; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., Medeiros-Fonseca B; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., Oliveira PA; Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro (UTAD), 5001-801 Vila Real, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal., M S M Bastos M; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal., Gil da Costa RM; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Center for the Research and Technology of Agro-Environmental and Biological Sciences (CITAB), University of Trás-os-Montes and Alto Douro (UTAD), 5001-911 Vila Real, Portugal.; LEPABE-Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal.; Postgraduate Programme in Adult Health (PPGSAD), Tumour and DNA Biobank, Federal University of Maranhão (UFMA), 65080-805 São Luís, Brazil., Medeiros R; Molecular Oncology and Viral Pathology Group, IPO Porto Research Center (CI-IPOP), Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; Faculty of Medicine of the University of Porto (FMUP), 4200-319 Porto, Portugal.; Virology Service, Portuguese Oncology Institute of Porto (IPO Porto), 4200-072 Porto, Portugal.; CEBIMED, Faculty of Health Sciences of the Fernando Pessoa University, 4249-004 Porto, Portugal.; Research Department of the Portuguese League Against Cancer-Regional Nucleus of the North (Liga Portuguesa Contra o Cancro-Núcleo Regional do Norte), 4200-177 Porto, Portugal.
Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2020 Jul 16; Vol. 21 (14). Date of Electronic Publication: 2020 Jul 16.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje